Shanghai ZJ Bio-Tech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,553	2,783	2,769	3,148	2,936
Trading Asset Securities	347.89	-	-	-	-
Cash & Short-Term Investments	2,901	2,783	2,769	3,148	2,936
Cash Growth	4.21%	0.50%	-12.02%	7.21%	143.70%
Accounts Receivable	31.79	55.27	102.1	227.63	218.39
Other Receivables	0.59	22.78	25.05	9.45	75.76
Receivables	32.38	78.05	127.15	237.08	294.15
Inventory	45.57	57.37	253.6	504.03	299.47
Other Current Assets	7.62	16.8	15.79	21.01	23.3
Total Current Assets	2,986	2,936	3,166	3,910	3,553
Property, Plant & Equipment	628.22	680.95	743.91	661.63	562.36
Long-Term Investments	64.93	95.46	101.05	113.46	74.97
Goodwill	5.4	5.4	5.4	5.4	5.4
Other Intangible Assets	7.04	7.8	6.06	6.84	6.57
Long-Term Deferred Tax Assets	68.81	60.8	37.16	9.46	7.44
Long-Term Deferred Charges	3.2	3.82	2.86	3.66	-
Other Long-Term Assets	-	0.11	11.71	33.55	45.1
Total Assets	3,764	3,790	4,074	4,744	4,255
Accounts Payable	55.4	62.46	120.58	317.67	236.95
Accrued Expenses	39.54	59.96	74.03	99.78	75.92
Current Portion of Long-Term Debt	11.74	-	-	-	-
Current Portion of Leases	-	1.73	2.81	2.94	-
Current Income Taxes Payable	3.96	0.09	0.01	26.82	32.28
Current Unearned Revenue	9	15.28	24.02	59.32	55.29
Other Current Liabilities	6.94	6.46	15.12	17.33	8.56
Total Current Liabilities	126.58	145.99	236.56	523.86	409
Long-Term Debt	284.26	-	-	-	-
Long-Term Leases	2.96	3.19	4.64	5.69	-
Long-Term Unearned Revenue	1.14	3.88	7.59	11.71	13.74
Long-Term Deferred Tax Liabilities	-	-	0.45	2.17	4.54
Total Liabilities	414.95	153.06	249.25	543.44	427.27
Common Stock	192.16	192.16	194.7	194.7	194.7
Additional Paid-In Capital	2,051	2,051	2,150	2,150	2,150
Retained Earnings	1,410	1,438	1,587	1,953	1,458
Treasury Stock	-294.44	-35.33	-102.03	-102.03	-
Comprehensive Income & Other	-9.87	-8.88	-4.51	4.73	24.35
Total Common Equity	3,349	3,637	3,825	4,200	3,827
Shareholders' Equity	3,349	3,637	3,825	4,200	3,827
Total Liabilities & Equity	3,764	3,790	4,074	4,744	4,255
Total Debt	298.97	4.93	7.45	8.63	-
Net Cash (Debt)	2,602	2,778	2,762	3,139	2,936
Net Cash Growth	-6.36%	0.60%	-12.01%	6.92%	143.70%
Net Cash Per Share	14.41	14.60	14.33	16.23	15.40
Filing Date Shares Outstanding	171.22	189.84	192.16	192.16	194.7
Total Common Shares Outstanding	171.22	189.84	192.16	192.16	194.7
Working Capital	2,860	2,790	2,929	3,386	3,144
Book Value Per Share	19.56	19.16	19.91	21.86	19.66
Tangible Book Value	3,336	3,624	3,813	4,188	3,815
Tangible Book Value Per Share	19.49	19.09	19.85	21.80	19.60
Buildings	-	770.99	757.66	639.77	547.36
Machinery	-	156.51	208.32	194.57	145.72
Construction In Progress	-	0.34	2.12	1.18	0.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.